TNDM and DXCM Related Headlines
Go Back- Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
- Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference
- Stifel resumes coverage on medtech names, sees long-term diabetes devices growth
- Oppenheimer sees stronger growth at Boston Scientific
